Kazuo Yano

Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan

Kazuo Yano, Natsumi Watanabe, Kenichiro Tsuyuki et al. · Regenerative Therapy · 2014 · 62 citations · Full text

Pharmacy, Biotechnology, Health Law +15

Comparison of the new Japanese legislation for expedited approval of regenerative medicine products with the existing systems in the USA and European Union

Yoji Jokura, Kazuo Yano, Masayuki Yamato · Journal of Tissue Engineering and Regenerative Medicine · 2017 · 38 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +15

Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product Glybera

Natsumi Watanabe, Kazuo Yano, Kenichiro Tsuyuki et al. · Molecular Therapy — Methods & Clinical Development · 2015 · 36 citations · Full text

Pharmacy, Biotechnology, Pharmaceutical Biotechnology +17

Compassionate use of drugs and medical devices in the United States, the European Union and Japan

Kenichiro Tsuyuki, Kazuo Yano, Natsumi Watanabe et al. · Regenerative Therapy · 2016 · 27 citations · Full text

Pharmacy, Pharmaceutical Policy, Clinical Medicine +14

The regulation of allogeneic human cells and tissue products as biomaterials

Kazuo Yano, Kenichiro Tsuyuki, Natsumi Watanabe et al. · Biomaterials · 2013 · 21 citations

Engineering, Biomedical Engineering, Biomaterials +13